Characterization of PTM-associated mutations that alter signaling network in breast and ovarian cancers.

改变乳腺癌和卵巢癌信号网络的 PTM 相关突变的表征。

• 批准号: 407419
• 负责人: Fradet-Turcotte Amlie
• 金额: $ 4.37万
• 依托单位: Universit Laval
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-02-01 至 2021-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407419&lang=en
• 关键词: Breast Cancer

Cancer is a widespread disease and Canadians have ~40% chance of being diagnosed with cancer during their life. Although the last years have witnessed the development of therapies that precisely kill certain types of cancer cells, we still struggle to ide

癌症是一种普遍的疾病，加拿大人一生中有40%的机会被诊断出患有癌症。尽管过去几年来已经有了精确杀死某些类型癌细胞的治疗方法，但我们仍然很难找到一种有效的治疗方法。